<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26734871</article-id>
      <article-id pub-id-type="pmc">4689078</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153793</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cutaneous metastasis of unknown primary presenting as massive and
invasive abdominal lesion: an elective approach<xref ref-type="fn" rid="fn1">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lido</surname>
            <given-names>Paolo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Paolino</surname>
            <given-names>Giovanni</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Feliziani</surname>
            <given-names>Andrea</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Santurro</surname>
            <given-names>Letizia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Montuori</surname>
            <given-names>Mauro</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Sanctis</surname>
            <given-names>Flavio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rossi</surname>
            <given-names>Piero</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Petrella</surname>
            <given-names>Giuseppe</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ricciardi</surname>
            <given-names>Edoardo</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fusano</surname>
            <given-names>Giuseppe</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Augusto</surname>
            <given-names>Orlandi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Polisca</surname>
            <given-names>Patrizio</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Universit&#xE0; degli Studi di Roma Tor Vergata &#x2013; Roma, Italia.</aff>
      <aff id="aff2"><label>2</label>Universit&#xE0; degli Studi di Roma &#x201C;La Sapienza&#x201D; - Roma,
Italia.</aff>
      <author-notes>
        <corresp id="c1">MAILING ADDRESS: Giovanni Paolino, La Sapienza University of
Rome, Viale del Policlinico 15, 00186 Rome, Italy. E-mail:
paolgio@libero.it</corresp>
        <fn fn-type="conflict">
          <p>Conflict of Interest: None</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>6</issue>
      <fpage>879</fpage>
      <lpage>882</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>6</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>02</day>
          <month>10</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2015 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of
the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We describe herein what is to our knowledge the first reported case of an
invasive cutaneous metastasis with unknown primary, electively treated
solely with electrochemotherapy. We describe a female patient with a large,
invasive and painful lesion in her hypogastric region, extending up to the
pubic area. The cutaneous biopsy and instrumental and laboratory analyses,
all failed to reveal the primary site. A final diagnosis of cutaneous
metastasis with unknown primary was made and treatment was performed with
electrochemotherapy. Our case highlights the importance of
interdisciplinary choices in clinical practice to cope with the lack of a
primary site and to improve quality of life, since no standardized therapy
exists for these classes of patients.</p>
      </abstract>
      <kwd-group>
        <kwd>Electrochemotherapy</kwd>
        <kwd>Neoplasm metastasis</kwd>
        <kwd>Neoplasms, unknown primary</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Among cutaneous metastases, those with unknown primary (CMUP), account for 4.4% of
all cases.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> Recent reports have found that in cases of
metastatic malignancies of unknown primary origin, primary sites are
identifiable in only 20-25% of cases before death.<sup><xref rid="r2" ref-type="bibr">2</xref></sup></p>
      <p>Since the average survival time following the appearance of a cutaneous metastasis
is 3-7.5 months, and because it sometimes presents as invasive lesions, an
appropriate diagnosis is needed to identify patients with treatable disease and
those with a more favorable prognosis.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup></p>
      <p>We describe a CMUP of the abdominal region, reporting the relative diagnostic
procedures and management involved. Given the impossibility of wide surgical
excision (and/or systemic chemotherapy) and due to the unusual histotype, we
opted for electrochemotherapy (ECT). ECT is a local treatment based on the
phenomenon of electroporation, characterized by the formation of pores (by
applying an electric field) in the cell-membrane, thus making it permeable and
enabling the passage of anti-neoplastic agents (such as bleomycin or cis-platin)
in the cytosol, resulting in a cytotoxic process.<sup><xref rid="r4" ref-type="bibr">4</xref></sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 54-year-old Caucasian woman presented to our department with a 6-month history
of a large and painful lesion on her hypogastric region, extending up to the
pubic area. The lesion was ulcerated, malodorous, bleeding, and ranged 15cm X
9cm in diameter. At the periphery of the lesion, several nodulations were
visible (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Large and painful lesion in the hypogastric region, extending up to the
pubic and supra pubic area. The lesion appeared ulcerated and
bleeding</p>
        </caption>
        <graphic xlink:href="abd-90-06-0879-g01"/>
      </fig>
      <p>The patient's past medical history was significant for HCV infection,
tonsillectomy and a cholecystectomy (treatment for gallstones). The physical
examination was negative for other noteworthy clinical signs.</p>
      <p>The histological examination of the incisional biopsy showed a dermal
proliferation, constituted by an infiltration of a poorly differentiated
adenocarcinoma, characterized by the presence of focal areas with psammomatous
aspects and clear cells (<xref ref-type="fig" rid="f2">Figure 2A</xref>).
Immunohistochemical studies showed that the tumor cells were reactive for
cytokeratin (CK) 7 and CK 5/6, while they were negative for CD10, CK 20 and WT1
(<xref ref-type="fig" rid="f2">Figure 2B</xref>). According to the biopsy,
an esophagus-gastro-duodenoscopy, a colonoscopy, trans-vaginal ultrasound,
bilateral mammography and bronchoscopy, were performed without evidence of the
primary malignancy. The computed tomography and the total-body positron emission
computed tomography revealed that the radiotracer was established in the
abdominal region, but without highlighting the primary site. The routine
laboratory investigations and dosages of the oncologic markers (including AFP,
&#x3B2;-HCG and CA125) did not show significant alterations.</p>
      <fig id="f2" orientation="portrait" position="float">
        <label>Figure 2</label>
        <caption>
          <p>A. Dermal proliferation, constituted by an infiltration of
undifferentiated adenocarcinoma with focal aspects of clear cells. (10
X, hematoxylin-eosin). B: Tumor cells positive for CK-7(10 X)</p>
        </caption>
        <graphic xlink:href="abd-90-06-0879-g02"/>
      </fig>
      <p>Based on the patient's history, the cutaneous biopsy and instrumental analyses, a
final diagnosis of CMUP was made.</p>
      <p>Given the extent of the skin lesions, the clinical features (pain, bleeding and
smelliness), the fact that oncological valuation did not present indications for
systemic chemotherapy, and following the patient's personal opinion, we
performed electrochemotherapy. The patient received intravenous bleomycin (at a
dosage of 26.5 mg) under general anesthesia, followed (8 minutes later) by
electroporation on the tumoral lesion through the pulse generator
Cliniporator<sup>TM</sup> (IGEA S.p.A, Carpi, Italy). A hexagonal array of
electrodes was used during this procedure. Subsequently, we arranged weekly
clinical follow-ups. At 60 days, we observed a complete response in peripheral
and smaller nodules, with a partial response in the biggest ones (over 3cm in
size) (<xref ref-type="fig" rid="f3">Figure 3</xref>). Pain and bleeding were
significantly reduced.</p>
      <fig id="f3" orientation="portrait" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Tumor lesion after about 60 days of electrochemotherapy. Complete
response in the peripheral and smaller nodules, with a partial
response in the biggest ones</p>
        </caption>
        <graphic xlink:href="abd-90-06-0879-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The patient's age, along with the cutaneous lesion's adenocarcinoma histotype,
corresponded to the clinical-pathological features of CMUP, most of which are
reported in the literature (2, 5). However, undifferentiated histotypes in the
CMUP spectrum are described in only 30% of these cases.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup></p>
      <p>Based on the anatomical region involved and the histopathological features, the
main differential diagnoses included cutaneous metastasis of an ovarian
adenocarcinoma and a primitive papillary serous neoplasia of the peritoneum
(PPSC).<sup><xref rid="r3" ref-type="bibr">3</xref></sup></p>
      <p>Cutaneous metastases occur in 3.5-4% of patients with ovarian carcinoma and tend
to appear late in the course of the disease.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Clinically, they are represented by multiple small
nodules, herpetiform erythematous lesions and/or scarring plaques, often
affecting the lower abdomen and anterior chest. Histologically, cutaneous
metastases from ovarian cancer reproduce a well-differentiated adenocarcinoma;
while upon immunohistochemistry they show positivity to CK7, CA125, and
negativity to CK20. However, in this case the instrumental negativity for a
primary ovarian carcinoma, associated with negativity to CA125, had determined a
valid discrimination in the diagnosis.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> PPSC is a rare tumor of the peritoneum, clinically
similar to an epithelial ovarian carcinoma, entailing a similar management
approach and overall survival rate. Currently, these two entities are
histologically indistinguishable and about 10% of epithelial ovarian cancers are
reclassified as PPSC.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> Age,
gender, CK7-positivity and the anatomical site affected were linked to a
diagnosis of PPSC. Nevertheless, the low levels of CA125 and negativity to WT1
deviated from a PPSC diagnosis. The primary site of our cutaneous lesion
remained unknown.</p>
      <p>Electrochemotherapy (ECT) has proven effective in treating several types of
neoplasia and guaranteeing an improvement in overall quality of life.<sup><xref rid="r7" ref-type="bibr">7</xref></sup> It combines chemotherapy and
electroporation to increase drug uptake into cancer cells. Further, in addition
to the well-established, direct cytotoxic effect on tumor cells, ECT has an
indirect vascular disrupting action, resulting in extensive tumor cell necrosis,
leading to complete regression of tumors.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> It is an excellent option for patients suffering from
cutaneous metastasis where other treatments have failed or cannot be
applied.<sup><xref rid="r9" ref-type="bibr">9</xref></sup> In our
case, ECT proved to be a valid palliative treatment, improving quality of life
(reducing pain, smelliness and bleeding), which is unfortunately very low among
these patients.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>In conclusion, reliable clinical information from careful morphological and
instrumental evaluation should help identify the cause of most CMUP cases, while
immunohistochemistry should be considered mainly in the rare instances of poorly
differentiated CMUP.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> The
absence of a standardized protocol for this class of patients and the poor
prognosis of adenocarcinoma in setting of unknown primary, require a
multidisciplinary approach. The reductions in bleeding and pain, together with
better adherence to ECT treatment by our patient, were the main focal points of
this case report.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Lido P, Paolino G, Feliziani A, Santurro L,
Montuori M, De Sanctis F, Rossi P, Petrella G, Ricciardi E, Fusano G,
Orlandi A, Polisca P. Cutaneous metastasis of unknown primary presenting as
massive and invasive abdominal lesion: an elective approach with
electrochemotherapy. An Bras Dermatol. 2015;90(6):879-82</p>
      </fn>
      <fn id="fn1" fn-type="other">
        <label>*</label>
        <p>Work performed at the Universit&#xE0; degli Studi di Roma &#x201C;La Sapienza&#x201D; and
Universit&#xE0; degli Studi di Roma Tor Vergata.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azoulay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Adem</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pelletier</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Barete</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Franc&#xE8;s</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Capron</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Skin metastases from unknown origin: role of
immunohistochemistry in the evaluation of cutaneous metastases of
carcinoma of unknown origin</article-title>
          <source>J Cutan Pathol</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>561</fpage>
          <lpage>566</lpage>
          <pub-id pub-id-type="pmid">16115055</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carroll</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Fleming</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chitambar</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Neuburg</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis, workup, and prognosis of cutaneous metastases of
unknown primar origin</article-title>
          <source>Dermatol Surg</source>
          <year>2002</year>
          <volume>28</volume>
          <fpage>533</fpage>
          <lpage>535</lpage>
          <pub-id pub-id-type="pmid">12081687</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alcaraz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cerroni</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>R&#xFC;tten</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kutzner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Requena</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous metatsases from internal malignancies: a
clinicopathologic and immunohistochemical review</article-title>
          <source>Am J Dermatopathol</source>
          <year>2012</year>
          <volume>34</volume>
          <fpage>347</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="pmid">22617133</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Juhasz-B&#xF6;ss</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Solomayer</surname>
              <given-names>EF</given-names>
            </name>
            <name>
              <surname>Herr</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Electrochemotherapy in Breast Cancer: A Review of
References</article-title>
          <source>Geburtshilfe Frauenheilkd</source>
          <year>2014</year>
          <volume>74</volume>
          <fpage>557</fpage>
          <lpage>562</lpage>
          <pub-id pub-id-type="pmid">24976637</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gabbia</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cascinu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Marchetti</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <source>Oncologia Medica Pratica</source>
          <edition>3. ed.</edition>
          <publisher-loc>Roma</publisher-loc>
          <publisher-name>Societ&#xE0; editrice Universo</publisher-name>
          <year>2010</year>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Primary peritoneal serous carcinoma: a clinicopathological
an immunohistochemical study of six cases</article-title>
          <source>Int J Clin Exp Pathol</source>
          <year>2012</year>
          <volume>5</volume>
          <fpage>762</fpage>
          <lpage>769</lpage>
          <pub-id pub-id-type="pmid">23071858</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Campana</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Mocellin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Basso</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Puccetti</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>De Salvo</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Chiarion-Sileni</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bleomycin-based electrochemotherapy: clinical outcome from a
single institution's experience with 52 patients</article-title>
          <source>Ann Surg Oncol</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>191</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="pmid">18987914</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sersa</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jarm</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kotnik</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Coer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Podkrajsek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sentjurc</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Vascular disrupting action of electroporation and
electrochemotherapy with bleomycin in murine sarcoma</article-title>
          <source>Br J Cancer</source>
          <year>2008</year>
          <volume>98</volume>
          <fpage>388</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="pmid">18182988</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Matthiessen</surname>
              <given-names>LW</given-names>
            </name>
            <name>
              <surname>Chalmers</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Sainsbury</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Veeramani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kessell</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Humphreys</surname>
              <given-names>AC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Management of cutaneous metastases using
electrochemotherapy</article-title>
          <source>Acta Oncol</source>
          <volume>50</volume>
          <fpage>621</fpage>
          <lpage>629</lpage>
          <pub-id pub-id-type="pmid">21574833</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jarm</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cemazar</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miklavcic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sersa</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Antivascular effects of electrochemotherapy: implications in
treatment of bleeding metastases</article-title>
          <source>Expert Rev Anticancer Ther</source>
          <year>2010</year>
          <volume>10</volume>
          <fpage>729</fpage>
          <lpage>746</lpage>
          <pub-id pub-id-type="pmid">20470005</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
